{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:50:02Z","timestamp":1775868602626,"version":"3.50.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Inborn errors of immunity (IEI) are an expanding group of rare diseases whose field has been boosted by next-generation sequencing (NGS), revealing several new entities, accelerating routine diagnoses, expanding the number of atypical presentations and generating uncertainties regarding the pathogenic relevance of several novel variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Research laboratories that diagnose and provide support for IEI require accurate, reproducible and sustainable phenotypic, cellular and molecular functional assays to explore the pathogenic consequences of human leukocyte gene variants and contribute to their assessment. We have implemented a set of advanced flow cytometry-based assays to better dissect human B-cell biology in a translational research laboratory. We illustrate the utility of these techniques for the in-depth characterization of a novel (c.1685G&amp;gt;A, p.R562Q) <jats:italic>de novo<\/jats:italic> gene variant predicted as probably pathogenic but with no previous insights into the protein and cellular effects, located in the tyrosine kinase domain of the Bruton\u2019s tyrosine kinase (BTK) gene, in an apparently healthy 14-year-old male patient referred to our clinic for an incidental finding of low immunoglobulin (Ig) M levels with no history of recurrent infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>A phenotypic analysis of bone marrow (BM) revealed a slightly high percentage of pre-B-I subset in BM, with no blockage at this stage, as typically observed in classical X-linked agammaglobulinemia (XLA) patients. The phenotypic analysis in peripheral blood also revealed reduced absolute numbers of B cells, all pre-germinal center maturation stages, together with reduced but detectable numbers of different memory and plasma cell isotypes. The R562Q variant allows Btk expression and normal activation of anti-IgM-induced phosphorylation of Y551 but diminished autophosphorylation at Y223 after anti IgM and CXCL12 stimulation. Lastly, we explored the potential impact of the variant protein for downstream Btk signaling in B cells. Within the canonical nuclear factor kappa B (NF-\u03baB) activation pathway, normal I\u03baB\u03b1 degradation occurs after CD40L stimulation in patient and control cells. In contrast, disturbed I\u03baB\u03b1 degradation and reduced calcium ion (Ca2<jats:sup>+<\/jats:sup>) influx occurs on anti-IgM stimulation in the patient\u2019s B cells, suggesting an enzymatic impairment of the mutated tyrosine kinase domain.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1095123","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T04:32:14Z","timestamp":1682310734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Research-based flow cytometry assays for pathogenic assessment in the human B-cell biology of gene variants revealed in the diagnosis of inborn errors of immunity: a Bruton\u2019s tyrosine kinase case-study"],"prefix":"10.3389","volume":"14","author":[{"given":"L.","family":"del Pino-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Y.","family":"Bravo Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Soto Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Reche Yebra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Marty Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gonz\u00e1lez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bravo Garc\u00eda-Morato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rodr\u00edguez Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00f3pez Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1473\u2013507","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.634181","article-title":"Update on infections in primary antibody deficiencies","volume":"12","author":"Demirdag","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.08.003","article-title":"Exome and genome sequencing for inborn errors of immunity","volume":"138","author":"Meyts","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12930","article-title":"The importance of functional validation after next-generation sequencing: evaluation of a novel CARD11 variant","volume":"29","author":"Lu","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.04.043","article-title":"A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia","volume":"116","author":"L\u00f3pez-Granados","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":":66-81","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0123","article-title":"Btk function in b cell development and response","volume":"10","author":"Satterthwaite","year":"1998","journal-title":"Semin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601285","article-title":"Distinct and overlapping functions of TEC kinase and BTK in b cell receptor signaling","volume":"198","author":"de Bruijn","year":"2017","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of bruton\u2019s tyrosine kinase in b cells and malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol Canc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01271","article-title":"EuroFlow-based flowcytometric diagnostic screening and classification of primary immunodeficiencies of the lymphoid system","volume":"10","author":"van Dongen","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00246","article-title":"The EuroFlow PID orientation tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system","volume":"10","author":"van der Burg","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal b-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.603972","article-title":"Dissection of the pre-germinal center b-cell maturation pathway in common variable immunodeficiency based on standardized flow cytometric EuroFlow tools","volume":"11","author":"del Pino-Molina","year":"2021","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02680","article-title":"Delineating human b cell precursor development with genetically identified PID cases as a model","volume":"10","author":"Wentink","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901117","article-title":"Phosphoflow protocol for signaling studies in human and murine b cell subpopulations","volume":"204","author":"Rip","year":"2020","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26212","article-title":"CXCR4-and BCR-triggered integrin activation in b-cell chronic lymphocytic leukemia cells depends on JAK2-activated bruton\u2019s tyrosine kinase","volume":"9","author":"Montresor","year":"2018","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119532","article-title":"Ratiometric analysis of fura red by flow cytometry: a technique for monitoring intracellular calcium flux in primary cell subsets","volume":"10","author":"Wendt","year":"2015","journal-title":"PloS One"},{"key":"B21","first-page":"59","article-title":"A case of bruton\u2019s disease with normal immunoglobulin G level","volume":"11","author":"Alyasin","year":"2014","journal-title":"Iranian J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2431-13-150","article-title":"Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin m deficiency patient","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02784.x","article-title":"Leaky phenotype of X-linked agammaglobulinaemia in a Japanese family","volume":"140","author":"Kaneko","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2011.03409.x","article-title":"Atypical case of X-linked agammaglobulinemia diagnosed at 45 years of age","volume":"53","author":"Fujioka","year":"2011","journal-title":"Pediatr Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":":e12811","DOI":"10.1111\/sji.12811","article-title":"Impaired polysaccharide responsiveness without agammaglobulinaemia in three patients with hypomorphic mutations in bruton tyrosine kinase\u2013no detection by newborn screening for primary immunodeficiencies","volume":"91","author":"Kr\u00fcger","year":"2020","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9262-8","article-title":"Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China","volume":"29","author":"Wang","year":"2009","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0052-y","article-title":"Four novel and three recurrent mutations of the BTK gene and pathogenic effects of putative splice mutations","volume":"51","author":"Wattanasirichaigoon","year":"2006","journal-title":"J Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-1229(95)90216-3","article-title":"Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting btk residues R562, W563, and A582","volume":"76","author":"Maniar","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22791","article-title":"Characterization of all possible single-nucleotide change caused amino acid substitutions in the kinase domain of bruton tyrosine kinase","volume":"36","author":"V\u00e4liaho","year":"2015","journal-title":"Hum Mutat"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(20000131)90:3<229::AID-AJMG8>3.0.CO;2-Q","article-title":"Twin carriers of X-linked agammaglobulinemia (XLA) due to germline mutation in the btk gene","volume":"90","author":"Curtis","year":"2000","journal-title":"Am J Med Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.2.276","article-title":"Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course","volume":"101","author":"Holinski-Feder","year":"1998","journal-title":"Pediatrics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.1.51","article-title":"DNA-Based mutation analysis of bruton\u2019s tyrosine kinase gene in patients with X-linked agammaglobulinaemia","volume":"4","author":"Vorechovsk\u00fd","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12803","article-title":"Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease","volume":"91","author":"Vihinen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1021\/bi8019756","article-title":"Activation loop phosphorylation modulates bruton\u2019s tyrosine kinase (Btk) kinase domain activity","volume":"48","author":"Lin","year":"2009","journal-title":"Biochemistry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2018.11.009","article-title":"Precursor b-cell development in bone marrow of good syndrome patients","volume":"200","author":"del Pino Molina","year":"2019","journal-title":"Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.02.017","article-title":"Defects in memory b-cell and plasma cell subsets expressing different immunoglobulin-subclasses in CVID and ig-subclass deficiencies","volume":"144","author":"Blanco","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311985200","article-title":"Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase c\u03b3 src homology 2-src homology 3 linker","volume":"279","author":"Humphries","year":"2004","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/bi0100788","article-title":"Bruton\u2019s tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling","volume":"40","author":"Qin","year":"2001","journal-title":"Biochemistry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03589.x","article-title":"Naturally occurring bruton\u2019s tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model","volume":"152","author":"P\u00e9rez De Diego","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(98)70471-3","article-title":"A role for bruton\u2019s tyrosine kinase (Btk) in platelet activation bycollagen","volume":"8","author":"Quek","year":"1137","journal-title":"Curr Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-163725","article-title":"Critical role of class IA PI3K for c-rel expression in b lymphocytes","volume":"113","author":"Matsuda","year":"2009","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80417-3","article-title":"Regulation of btk function by a major autophosphorylation site within the SH3 domain","volume":"4","author":"Park","year":"1996","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535799","article-title":"Roles for phosphoinositide 3-kinases, bruton\u2019s tyrosine kinase, and jun kinases in b lymphocyte chemotaxis and homing","volume":"36","author":"Ortolano","year":"2006","journal-title":"Eur J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.10.1745","article-title":"Bruton\u2019s tyrosine kinase is required for activation of I b kinase and nuclear factor b in response to b cell receptor engagement","volume":"191","author":"Petro","year":"2000","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.10.1735","article-title":"Bruton\u2019s tyrosine kinase links the b cell receptor to nuclear factor b activation","volume":"191","author":"Bajpai","year":"2000","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.591577","article-title":"Genetic and non-genetic mechanisms of resistance to BCR signaling inhibitors in b cell malignancies","volume":"10","author":"Ondrisova","year":"2020","journal-title":"Front Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1095123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T06:00:55Z","timestamp":1682920855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1095123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2023.1095123"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1095123","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"article-number":"1095123"}}